Verastem appoints Anil Kapur to Board of Directors; effective October 20, 2022

Verastem, Inc.

Anil Kapur elected as Class III director, effective Oct 20, 2022; will serve on compensation committee, term through 2024 annual meeting.
Received stock option grant of 163,185 shares; eligible for annual cash retainer and option grants under director compensation policy.
Kapur is EVP, Corporate Strategy & CCO at Geron Corporation, with 25+ years oncology experience.
Board determined Kapur is independent per Nasdaq listing standards.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Anil Kapur

Class III director

VSTM · Verastem, Inc.

Effective: 2022-10-20
Filed: October 20, 2022, 7:59 PM ET

On October 19, 2022, the board of directors (the “Board”) of Verastem, Inc. (the “Company”) unanimously voted to elect Anil Kapur as a Class III director of the Company and to serve on the compensation committee of the Board, effective October 20, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anil Kapur was elected as Class III director at Verastem, Inc..

Action: elected
Role: Class III director

Exact text from the filing

On October 19, 2022, the board of directors (the “Board”) of Verastem, Inc. (the “Company”) unanimously voted to elect Anil Kapur as a Class III director of the Company and to serve on the compensation committee of the Board, effective October 20, 2022.

View on SEC.gov

Verastem, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-015095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.